JP2018035153A5 - - Google Patents

Download PDF

Info

Publication number
JP2018035153A5
JP2018035153A5 JP2017163690A JP2017163690A JP2018035153A5 JP 2018035153 A5 JP2018035153 A5 JP 2018035153A5 JP 2017163690 A JP2017163690 A JP 2017163690A JP 2017163690 A JP2017163690 A JP 2017163690A JP 2018035153 A5 JP2018035153 A5 JP 2018035153A5
Authority
JP
Japan
Prior art keywords
genus
versus
graft
host disease
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017163690A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018035153A (ja
JP6408092B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018035153A publication Critical patent/JP2018035153A/ja
Publication of JP2018035153A5 publication Critical patent/JP2018035153A5/ja
Application granted granted Critical
Publication of JP6408092B2 publication Critical patent/JP6408092B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017163690A 2016-08-29 2017-08-28 糞便微生物叢を含む組成物 Active JP6408092B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016166656 2016-08-29
JP2016166656 2016-08-29

Publications (3)

Publication Number Publication Date
JP2018035153A JP2018035153A (ja) 2018-03-08
JP2018035153A5 true JP2018035153A5 (enExample) 2018-05-17
JP6408092B2 JP6408092B2 (ja) 2018-10-17

Family

ID=61565352

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017163690A Active JP6408092B2 (ja) 2016-08-29 2017-08-28 糞便微生物叢を含む組成物

Country Status (2)

Country Link
US (2) US20180185421A1 (enExample)
JP (1) JP6408092B2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3062063B1 (fr) * 2017-01-26 2019-04-19 Centre National De La Recherche Scientifique Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques
EP3806875A1 (en) * 2018-06-14 2021-04-21 4D Pharma Research Limited Compositions comprising bacterial strains
MX2018010105A (es) * 2018-08-21 2020-02-24 Centro De Investig Y Asistencia En Tecnologia Y Diseno Del Estado De Jalisco A C Sistema de estabilización de microbiota intestinal humana.
US12144834B2 (en) 2018-09-13 2024-11-19 Xbiome Inc. Methods and compositions for treating gastrointestinal and inflammatory disorders
JP2022532162A (ja) * 2019-05-06 2022-07-13 シンセティック・バイオロジクス・インコーポレイテッド 移植片対宿主病の処置のためのβ－ラクタマーゼ組成物
JPWO2021106952A1 (enExample) * 2019-11-26 2021-06-03

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
JPWO2005032589A1 (ja) * 2003-10-02 2007-11-15 独立行政法人科学技術振興機構 Ｇｖｈｄの予防及び治療
WO2011151941A1 (ja) * 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
EP4477750A3 (en) * 2011-12-01 2025-03-26 The University of Tokyo Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
US20150297642A1 (en) * 2012-11-26 2015-10-22 Thomas Julius Borody Compositions for the restoration of a fecal microbiota and methods for making and using them
RU2015140610A (ru) * 2013-03-14 2017-04-17 ТЕРАБАЙОМ, ЭлЭлСи Направленная доставка в желудочно-кишечный тракт пробиотических микроорганизмов и/или терапевтических средств
WO2014145958A2 (en) * 2013-03-15 2014-09-18 Seres Health, Inc. Network-based microbial compositions and methods
KR102671643B1 (ko) * 2013-10-25 2024-05-31 파마싸이클릭스 엘엘씨 이식편 대 숙주 질환의 치료 및 예방 방법
KR102314825B1 (ko) * 2013-11-04 2021-10-20 아이소포젠 피티와이 리미티드 세포 배양 방법
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
WO2016086161A1 (en) * 2014-11-25 2016-06-02 Memorial Sloan-Kettering Cancer Center Intestinal microbiota and gvhd

Similar Documents

Publication Publication Date Title
JP2018035153A5 (enExample)
JP2014158488A5 (enExample)
FI3146065T3 (fi) Menetelmiä ja koostumuksia clostridium difficile -infektion vähentämiseksi
JP2018039833A5 (enExample)
JP2018100276A5 (enExample)
JP2015213501A5 (enExample)
JP2018012698A5 (enExample)
WO2015134808A3 (en) Probiotic formulations and methods for use
JP2019508486A5 (enExample)
CO6251326A2 (es) Un exopolisacarido
RU2016143195A (ru) Применение lactobacilius rhamnosus для стимулирования восстановления разнообразия кишечной микробиоты после дисбактериоза
JP2012120528A5 (enExample)
MX383749B (es) Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas
WO2015121458A3 (fr) Utilisations de compositions comprenant du bifidobacterium animalis ssp. lactis lmg p-28149
JP2019104717A5 (enExample)
JP2017019841A5 (enExample)
WO2016198170A8 (en) Vaccines against streptococcus pneumoniae serotype 5
JP2015521034A5 (enExample)
JP2020137724A5 (enExample)
EP4470625A3 (en) A pharmaceutical composition comprising a combination of probiotic and prebiotic to treat stunting
JP2016508368A5 (enExample)
JP2018043949A5 (enExample)
JP2013032308A5 (enExample)
JP2020137723A5 (enExample)
JP2016003187A5 (enExample)